Full Stack Engineer, Verisian
+ Employee Stock Options Plan
More information about location
Accelerating drug time-to-market
Open for applications
Accelerating drug time-to-market
1-20 employees
Open for applications
+ Employee Stock Options Plan
More information about location
1-20 employees
Company mission
To empower researchers and regulators to analyse and monitor studies transparently in real-time, leading to improved and safer therapies for devastating diseases.
Role
Who you are
- Extensive experience with TypeScript and React
- Extensive experience with Next.js, Express.js, and async Node.js frameworks
- Extensive experience with HTML/CSS layouting, cross-browser compatibility, and responsive design
- Extensive experience developing client-server applications
- Experience identifying and resolving performance and scalability issues
- Experience in unit and integration testing, build and release management (CI/CD, GitHub Actions or similar)
- Experience with cloud infrastructures like Kubernetes and Docker
- Experience working with AWS, Azure, and GCP
- Strong focus on building and working as a team
- We and mission mindset
- Proven ability to communicate complex technical problems and solutions
- ‘If it’s not code and documented, it doesn’t exist’ mindset
- Iteration mindset
Desirable
- Experience with graph or network visualization (Reactflow, Graphviz, D3 or similar)
- Experience with Tailwind or similar frameworks
- Experience with graph theory or algorithms
What the job involves
- As a Full Stack Software Engineer, you will join our world-class engineering team in building the Verisian Platform
- You will work on a Next.js-based application that exposes our clinical trial insights to statistical programmers, statisticians, and reviewers
- We are building a variety of visualizations using exciting libraries (reactflow, d3, lineup.js) to provide our customers with a maximum of insight, drawing from extensive data pipelines that process the code used to analyze clinical trials
- The Verisian Explorer and Validator form the foundation of the Verisian Platform, which brings value to a highly regulated process for crucial medical progress and innovation
- Beyond feature development and bug hunting, you will therefore also be responsible for extensive automated testing and participation in building and deployment
- The Explorer and Validator target the exploration, knowledge transfer, and quality control processes of clinical trials and will enable statistical programmers to deliver their work faster, at higher quality, lower cost, and in greater confidence
- As part of our core team, you will join us in building and testing new functionality, troubleshooting customer issues, finding root causes, and deploying required fixes to ensure maximal user impact and performance
- Our application stack is currently based on Next.js and deployed via Docker/Kubernetes in the cloud
- We run code analysis pipelines based on Antlr4 and Java
- Git is where our code lives, and Github Actions is how it gets out into the world
- We currently focus on our core products: the Verisian Explorer and Validator
- Our tooling automatically extracts full dataset and column-level data lineages and dependencies from existing clinical trials to enable validation, understanding, modification, communication, as well as trial code and data reuse
- This means clinical trials are analyzed and validated faster, better, and at lower costs to the benefit of all of humanity
- By joining us, you will commit yourself to building software that enables the analysis and faithful assessment of clinical trial outcomes, to make the world a healthier place for everyone
Application process
- Please note the interview process for this role will start in October, with expected start dates in December 2025-January 2026
Salary benchmarks
Our take
Drug development times are painfully long, with patients waiting years upon years for new medicines to hit the market. Verisian is hoping to change this, with a range of tools to facilitate faster drug trialling and analysis of results.
The company's products target known pain-points in the clinical trial pipeline. For example, Verisian Builder allows trials to be designed faster by supplying a library of pre-approved modules based on existing studies. Trials can be pooled for analysis with Verisian Pooler, while data can be extracted and virtualised with Verisian Tracer.
Verisian is advancing its mission to streamline clinical trails with the release of its first product, Validator, which traces data lineage in SAS outputs to support automated study validation. Now, the team is focused on developing Builder, an AI-powered tool for designing and validating studies, while expanding partnerships with tier-1 pharmaceutical companies.
Kirsty
Company Specialist at Welcome to the Jungle
Company
Funding (1 round)
Sep 2023
$1.4m
SEED
Total funding: $1.4m
Company HQ
Westminster, London, UK
Leadership
Tomás Sabat
(Co-Founder & CEO)Previously on the Founding Team at Vaticle, where they spent 6 years as COO. Obtained an MPhil from the University of Cambridge.
Henning Kuich
(Co-Founder & CTO)Earned a PhD in Systems Biology from Freie Universität Berlin. Spent 7 years at Bayer Pharmaceuticals, ultimately as Senior Computational Scientist.
Share this job
View 1 more job at Verisian